Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Famon Awal Bros Sedaya TbkISX:PRAY 87 Debt-to-EBITDA is 4.61 as of Mar. 2026, which is 27% above its 10-year median of 3.63. GuruFocus rates ISX:PRAY with a GF Score™ of 87/100 and a GF Value™ of Rp886.57 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 476 Healthcare Providers & Services companies, PT Famon Awal Bros Sedaya Tbk ranks worse than 76.68% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA or its related term are showing as below:
ISX:PRAY'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.36 Med: 3.63 Max: 6.27
Current: 5.29
During the past 7 years, the highest Debt-to-EBITDA Ratio of PT Famon Awal Bros Sedaya Tbk was 6.27. The lowest was 1.36. And the median was 3.63.
ISX:PRAY's Debt-to-EBITDA is ranked worse than 76.68% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 2.195
vs ISX:PRAY: 5.29
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
PT Famon Awal Bros Sedaya Tbk Debt-to-EBITDA Related Terms
PT Famon Awal Bros Sedaya Tbk Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Famon Awal Bros Sedaya Tbk Debt-to-EBITDA Chart
ISX:PRAY vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Famon Awal Bros Sedaya Tbk Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) has a Debt-to-EBITDA of 4.61 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PT Famon Awal Bros Sedaya Tbk. This is 27% above median its historical median of 3.63. Over the past decade, PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA has ranged from 1.36 to 6.27. According to the industry distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #365 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 76.7%.
Is PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA too high?
PT Famon Awal Bros Sedaya Tbk's current Debt-to-EBITDA of 4.61 is 27% above median its 10-year median of 3.63. Over the past 10 years, this metric has ranged from a low of 1.36 to a high of 6.27. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. PT Famon Awal Bros Sedaya Tbk's value of 4.61 is 110% above this industry median. Based on the distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #365 out of 476 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Famon Awal Bros Sedaya Tbk has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Famon Awal Bros Sedaya Tbk's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #365 out of 476 companies for Debt-to-EBITDA. This places PT Famon Awal Bros Sedaya Tbk in the lower half of its industry. The industry median Debt-to-EBITDA is 2.20. PT Famon Awal Bros Sedaya Tbk's value of 4.61 is 110% above this benchmark. Historically, PT Famon Awal Bros Sedaya Tbk's own Debt-to-EBITDA has ranged from 1.36 to 6.27 over the past decade. While the company's 10-year median is 3.63 vs. the industry median of 2.20, PT Famon Awal Bros Sedaya Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Famon Awal Bros Sedaya Tbk's current Debt-to-EBITDA of 4.61 is 110% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PT Famon Awal Bros Sedaya Tbk. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Famon Awal Bros Sedaya Tbk's current Debt-to-EBITDA is 4.61, which is 27% above median its own 10-year median of 3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Famon Awal Bros Sedaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp886.57, compared to a current price of Rp745.00 — trading 16% below its estimated fair value. The current Debt-to-EBITDA is 4.61, which is 27% above median its 10-year median of 3.63 and 110% above the Healthcare Providers & Services industry median of 2.20. PT Famon Awal Bros Sedaya Tbk's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For PT Famon Awal Bros Sedaya Tbk (ISX:PRAY), the current Debt-to-EBITDA is 4.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Overvalued in 2026?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk stock appears to be undervalued.
The current stock price of Rp745.00 is trading 16% below its estimated GF Value™ of Rp886.57.
GuruFocus considers PT Famon Awal Bros Sedaya Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRAY:
Debt-to-EBITDA: 4.61 (27% above median its 10-year median of 3.63)
GF Value™: Rp886.57 vs. price of Rp745.00 (16% below fair value)
Industry Position: 110% above the Healthcare Providers & Services median (#365 of 476)
No single metric tells the full story. See the ISX:PRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Famon Awal Bros Sedaya Tbk operates as a hospital. The company7 provides comprehensive health services for Indonesians and foreign nationals (foreigners) and provides patient services with guarantees from companies, insurance, BPJS, and personal payments. Its hospital network has spread across different cities in Indonesia, including Jakarta, Bekasi, Tangerang, Semarang, Sukabumi, Makassar, Palangkaraya, and Pangkal Pinang. The services that it provides for patients include heart and blood vessel service centers, mother and child services, sports clinic & orthopedic services, cancer services, eye care centers & urology centers. The company's segments are Java; Kalimantan dan/ and Sulawesi; and Sumatera. It derives maximum revenue from Jawa.
87GF Score
Get the complete analysis for ISX:PRAY
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRAY has been successfully added to your 
